Pharma company Gufic buys Lodha Avalon duplex in Juhu for ₹236 crore
The purchase adds to a growing list of high-value deals at Lodha Developers’ luxury Mumbai project, which has attracted pharmaceutical promoters and business executives.
The purchase adds to a growing list of high-value deals at Lodha Developers’ luxury Mumbai project, which has attracted pharmaceutical promoters and business executives.
The Mumbai-based developer is expanding beyond its traditional markets as it prepares a residential launch in Gurugram and builds a ₹20,000 crore housing launch pipeline for the second half of FY27.
Ambani-owned Reliance's profit jumps 41% on refining, Jio strength Reuters RIL Q2 profit jumps 41% to ₹25,548 crore on O2C, Jio strength The Hindu Q2 Results Today Highlights: GAIL, IOC, Sun Pharma, Aditya Birla, BOB, Aether, Smartworks...
Election maps aren't always easy to understand. AP's Humera Lodhi breaks down how to use and interpret results maps ahead of the 2026 midterms.